Structure--activity relationships in cephalosporins prepared from penicillins. 1. 7beta-Acylamino derivatives of 3-benzyl- and 3-(3-pyridylmethyl)ceph-3-em-4-carboxylic acids. 1977

E G Brain, and A J Eglington, and J H Nayler, and N F Osborne, and M J Pearson, and T C Smale, and R Southgate, and P Tolliday, and M J Basker, and R Sutherland

tert-Butyl 7beta-aminoceph-3-em-4-carboxylates carrying either benzyl or 3-pyridylmethyl substituents at position 3 have been prepared by a multistep modification of the penicillin nucleus. Acylation of either amine, followed by deprotection, gave a range of new cephalosporins. The relationship between structure and antibacterial activity is discussed. D-Phenylglycine proved to be a preferred side chain in both series.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D001593 Benzyl Compounds Benzene derivatives that contain a benzyl group with the general formula Phenyl-CH2-R. Compounds, Benzyl
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

E G Brain, and A J Eglington, and J H Nayler, and N F Osborne, and M J Pearson, and T C Smale, and R Southgate, and P Tolliday, and M J Basker, and R Sutherland
May 1983, The Journal of antibiotics,
E G Brain, and A J Eglington, and J H Nayler, and N F Osborne, and M J Pearson, and T C Smale, and R Southgate, and P Tolliday, and M J Basker, and R Sutherland
June 1976, Journal of medicinal chemistry,
E G Brain, and A J Eglington, and J H Nayler, and N F Osborne, and M J Pearson, and T C Smale, and R Southgate, and P Tolliday, and M J Basker, and R Sutherland
January 1974, Journal of medicinal chemistry,
E G Brain, and A J Eglington, and J H Nayler, and N F Osborne, and M J Pearson, and T C Smale, and R Southgate, and P Tolliday, and M J Basker, and R Sutherland
January 1968, Journal of medicinal chemistry,
E G Brain, and A J Eglington, and J H Nayler, and N F Osborne, and M J Pearson, and T C Smale, and R Southgate, and P Tolliday, and M J Basker, and R Sutherland
May 1989, Journal of medicinal chemistry,
E G Brain, and A J Eglington, and J H Nayler, and N F Osborne, and M J Pearson, and T C Smale, and R Southgate, and P Tolliday, and M J Basker, and R Sutherland
November 1974, Helvetica chimica acta,
E G Brain, and A J Eglington, and J H Nayler, and N F Osborne, and M J Pearson, and T C Smale, and R Southgate, and P Tolliday, and M J Basker, and R Sutherland
March 1972, Helvetica chimica acta,
E G Brain, and A J Eglington, and J H Nayler, and N F Osborne, and M J Pearson, and T C Smale, and R Southgate, and P Tolliday, and M J Basker, and R Sutherland
April 1989, Journal of medicinal chemistry,
E G Brain, and A J Eglington, and J H Nayler, and N F Osborne, and M J Pearson, and T C Smale, and R Southgate, and P Tolliday, and M J Basker, and R Sutherland
July 1987, Chemical & pharmaceutical bulletin,
E G Brain, and A J Eglington, and J H Nayler, and N F Osborne, and M J Pearson, and T C Smale, and R Southgate, and P Tolliday, and M J Basker, and R Sutherland
October 1981, The Journal of antibiotics,
Copied contents to your clipboard!